Journal of Nutrition

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kushi, L. H.
Right arrow Articles by Teas, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kushi, L. H.
Right arrow Articles by Teas, J.

© 2001 The American Society for Nutritional Sciences J. Nutr. 131:3056S-3064S, November 2001


Supplement: AICR's 11th Annual Research Conference on Diet, Nutrition and Cancer

The Macrobiotic Diet in Cancer1 ,2

Lawrence H. Kushi, Joan E. Cunningham{dagger},**, James R. Hebert**, Robert H. Lerman{ddagger}, Elisa V. Bandera{dagger}{dagger} and Jane Teas{ddagger}{ddagger}

Program in Nutrition, Department of Health & Behavior Studies, Teachers College, Columbia University, New York, NY; Herbert Irving Comprehensive Cancer Center, Columbia-Presbyterian Medical Center, New York, NY; Department of Epidemiology and Biostatistics, Norman J. Arnold School of Public Health, University of South Carolina, Columbia, SC; The Institute for Functional Medicine and Functional Medicine Research Center, Metagenics, Inc., Gig Harbor, WA; Department of Nutritional Sciences, Rutgers University, New Brunswick, NJ; and Department of Health Promotion, Research and Education, Norman J. Arnold School of Public Health, University of South Carolina, Columbia, SC {ddagger}{ddagger} {dagger}{dagger} {ddagger} ** {dagger} *

3To whom correspondence should be addressed. E-mail: lhk26{at}columbia.edu.

Macrobiotics is one of the most popular alternative or complementary comprehensive lifestyle approaches to cancer. The centerpiece of macrobiotics is a predominantly vegetarian, whole-foods diet that has gained popularity because of remarkable case reports of individuals who attributed recoveries from cancers with poor prognoses to macrobiotics and the substantial evidence that the many dietary factors recommended by macrobiotics are associated with decreased cancer risk. Women consuming macrobiotic diets have modestly lower circulating estrogen levels, suggesting a lower risk of breast cancer. This may be due in part to the high phytoestrogen content of the macrobiotic diet. As with most aspects of diet in cancer therapy, there has been limited research evaluating the effectiveness of the macrobiotic diet in alleviating suffering or prolonging survival of cancer patients. The few studies have compared the experience of cancer patients who tried macrobiotics with expected survival rates or assembled series of cases that may justify more rigorous research. On the basis of available evidence and its similarity to dietary recommendations for chronic disease prevention, the macrobiotic diet probably carries a reduced cancer risk. However, at present, the empirical scientific basis for or against recommendations for use of macrobiotics for cancer therapy is limited. Any such recommendations are likely to reflect biases of the recommender. Because of its popularity and the compelling evidence that dietary factors are important in cancer etiology and survival, further research to clarify whether the macrobiotic diet or similar dietary patterns are effective in cancer prevention and treatment is warranted.


KEY WORDS: • macrobiotic diet • neoplasms • vegetarianism • life change events • yin-yang • epidemiology




This article has been cited by other articles:


Home page
Int J EpidemiolHome page
V. Mai, A. K Kant, A. Flood, J. V Lacey Jr, C. Schairer, and A. Schatzkin
Diet quality and subsequent cancer incidence and mortality in a prospective cohort of women
Int. J. Epidemiol., February 1, 2005; 34(1): 54 - 60.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
J. Wunder and S. L. Warber
Integrative Tumor Board: Recurrent Lymphoma
Integr Cancer Ther, September 1, 2004; 3(3): 243 - 246.
[PDF]


Home page
The OncologistHome page
B. R. Cassileth and G. Deng
Complementary and Alternative Therapies for Cancer
Oncologist, February 1, 2004; 9(1): 80 - 89.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2001 by American Society for Nutrition